Alnylam Pharmaceuticals (ALNY) PT Raised to $307 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $307.00 (from $295.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
